Search
Advanced search
Filter by category
Filter by committee
Search results
-
The workshop will identify priorities and gaps in manufacturing technology. ASTM International and the Association for the Advancement of Medical Instrumentation ( AAMI ) are partnering to host a healthcare innovation workshop to be held Tuesday, Nov. 12, 2024 at the Renaissance Orlando at SeaWorld, Orlando, FL in conjunction with ASTM November Committee Week . Building on an initial workshop…, Media Inquiries:, Gavin O’Reilly, tel +1.610.832.9618; goreilly@astm.org, Committee Contact:, Tessa Llewelyn, tel +1.610.832.9677; tllewelyn@astm.org Release #11886 ###
-
Registration is now open for ASTM International’s Workshop on Microbiological Quality Levels , to be held May 7, 2024, in Philadelphia, PA. The event is sponsored by ASTM International’s manufacture of pharmaceutical and biopharmaceutical products committee ( E55 ) and will be held in conjunction with the committee’s standards development meetings. Manufacturing pharmaceutical and…, Symposia Operations Contact:, Tammy Schane tel+1.610.832.9522, symposia@astm.org Release #11813 ###
-
ASTM International’s particle and spray characterization committee ( E29 ) is developing a proposed standard that will be used to measure physical and chemical properties of nanoparticles in a variety of industrial realms. The standard ( E3427 ) describes how to use laser-amplified detection/power spectrum analysis to measure the number of physical and chemical properties of nanoparticles,…, Media Inquiries:, Gavin O’Reilly, tel +1.610.832.9618; goreilly@astm.org, Committee Contact:, Jennifer Tursi, tel +1.610.832.9653; jtursi@astm.org Release #11790 ###
-
ASTM International is hosting the Radiation Processing for the Pharmaceutical and BioPharmaceutical Industries training workshop, to be held May 8 - 9, 2023, at the Sheraton Denver Downton Hotel (Colorado, USA). The workshop is organized by ASTM committees on manufacture of pharmaceutical and biopharmaceutical products (E55) and radiation processing (E61), and will take place in conjunction with…, ., The event will be held at the Sheraton Denver Downtown Hotel in Denver, Colorado., Attendance will be limited to the first 50 participants who register., Additional information is available from the members of the workshop’s planning committee, Maria Leyva ( Maria_Levya@Jabil.com ), Denise Cleghorn ( Denise.Cleghorn@bsci.com ), Samuel Dorey ( Samuel.DOREY@SARTORIUS.com ), Krystan Polaski ( Kyrstan_Polaski@steris.com ), John Williams ( john.a.williams@medtronic.com ). For more information about the workshop, visit https://go.astm.org/2023-radiation…, Symposia Operations Contact:, Tammy Schane, tel+1.610.832.9522, symposia@astm.org Release #11594 ###
-
Anthony Wayne Thornton, former member of the ASTM International board of directors, was awarded the William T. Cavanaugh Memorial Award at a ceremony held Oct. 19, during ASTM’s standards development meetings in New Orleans. Joining Thornton at the award ceremony were ASTM International President Kathie Morgan and Cesar Constantino, ASTM’s 2022 board chair. The Cavanaugh Memorial Award honors W.T…, Media Inquiries:, Dan Bergels, tel +1.610.832.9602; dbergels@astm.org Release #11556 ###
-
ASTM International’s manufacture of pharmaceutical and biopharmaceutical products committee ( E55 ) has approved a new standard that will help advance the use of continuous manufacturing (CM) technologies in the biopharmaceutical industry. In a CM process, individual unit operations are integrated into a connected flow which provides multiple efficiencies in terms of scale and productivity. “…, Media Inquiries:, Dan Bergels, tel +1.610.832.9602; dbergels@astm.org, Committee Contact:, Travis Murdock, tel +1.610.832.9826; tmurdock@astm.org Release #11543 ###
-
A proposed ASTM International standard will help advance the concept of lyophilization (freeze-drying) as it is used in the pharmaceutical and biotechnology industries. ASTM’s committee on manufacture of pharmaceutical and biopharmaceutical products ( E55 ) is developing the proposed standard. “The proposed standard will promote a deeper understanding of the science and engineering of…
-
A proposed ASTM International standard will be used to aid physical integrity testing of single-use systems (SUS) in the pharmaceutical and biopharmaceutical industries. SUS equipment has become a popular alternative to stainless steel equipment that has been generally used for biopharmaceutical manufacturing processes. ASTM International’s committee on manufacture of pharmaceutical and…
-
Particle size distribution is an important factor in the manufacture of many products, from cement to perfume. A proposed ASTM International standard ( WK45240 ) will set out a general approach to the particle size distribution measurement of powders, suspensions, or slurries using an appropriate wet or dry methodology by the laser diffraction technique. ASTM’s committee on particle and spray…
-
Global standards organization ASTM International and the biopharmaceutical industry collaboration group BioPhorum have signed a memorandum of understanding (MoU) aimed at accelerating standardization within the biopharmaceutical industry. The MoU is focused on accelerating innovation and advancement in bio and new modality manufacturing to bring solutions to patients faster. By formalizing this…, About ASTM International, Committed to serving global societal needs, ASTM International positively impacts public health and safety, consumer confidence, and overall quality of life. We integrate consensus standards – developed with our international membership of volunteer technical experts – and innovative services to improve lives… Helping our world work better., About BioPhorum, BioPhorum is a coordinated program of industry change, with a reputation for creating an environment where the global biopharmaceutical industry can collaborate and accelerate their rate of progress, for the benefit of all., ASTM Media Inquiries:, Dan Bergels, tel +1.610.832.9602; dbergels@astm.org , BioPhorum Media Inquiries:, Claire Astle, Claire.astle@biophorum.com Release #11361 ###